PetMed Express, Inc. (PETS) - Form 8-K Summary
Business Context and Reporting Period
PetMed Express, Inc., a Florida-based company trading on the NASDAQ Global Select Market under the symbol "PETS," filed this Current Report on June 11, 2024. The filing serves to announce the Company's financial results for the fourth quarter and full fiscal year ended March 31, 2024.
Key Financial Metrics
The provided text is a cover document referencing a press release (Exhibit 99.1) for detailed data. Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this filing text. The Company indicated it would utilize non-GAAP financial measures in its reporting, with reconciliations to GAAP measures provided in the referenced press release.
Material Changes
This filing does not contain specific comparative data or material changes versus prior periods. It solely notifies investors of the release of Q4 and full-year 2024 results.
Guidance, Outlook, and Management Commentary
Management scheduled a conference call for June 11, 2024, at 4:30 pm Eastern time to review the financial results. The filing explicitly states that the information contained herein and in the attached press release is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section, except as expressly set forth by specific reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated June 11, 2024) for specific revenue, net income, and cash flow figures.
- Examine the reconciliation of non-GAAP financial measures to GAAP measures included in the press release.
- Verify the details of the conference call transcript for management's commentary on the fiscal year performance.
- Confirm the Company's liquidity position and debt obligations as detailed in the full financial statements referenced in the press release.